Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GF Fund is a Chinese asset management company focused on public funds, institutional asset management, pension-related mandates, and cross-border investment services. Founded in 2003, the firm manages mutual funds and other investment products rather than developing therapeutics, medical technologies, or healthcare services. Its business includes domestic and international asset management through subsidiaries in Hong Kong and mainland China. Although some of its investment products may hold healthcare or biotech securities, GF Fund itself is not a life sciences, biotech, pharma, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GF Fund.